Skip to Main Content

Paper Details

Advances in the treatment of metastatic prostate cancer.
1
2023
AR, Lu-PSMA-617, PARP, PARPis, androgen, androgen receptor, docetaxel, lutetium-177 vipivotide tetraxetan, mPCa, metastatic prostate cancer, poly(ADP) ribose
Author NameAffiliation
Neeraj AgarwalHuntsman Cancer Institute, University of Utah
  • 1 - 1

Datasets

Release 1.2